BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29351409)

  • 1. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
    Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.
    Yang K; Lu W; Jiang Q; Yun X; Zhao M; Jiang H; Wang J
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):882-92. PubMed ID: 26020612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.
    Wang J; Yang K; Xu L; Zhang Y; Lai N; Jiang H; Zhang Y; Zhong N; Ran P; Lu W
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):231-40. PubMed ID: 23526219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis.
    Jiang Q; Lu W; Yang K; Hadadi C; Fu X; Chen Y; Yun X; Zhang J; Li M; Xu L; Tang H; Yuan JX; Wang J; Sun D
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C136-49. PubMed ID: 27194472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
    Han X; Chen C; Cheng G; Liang L; Yao X; Yang G; You P; Shou X
    Microvasc Res; 2015 Jul; 100():17-24. PubMed ID: 25937083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GW1929 inhibits α7 nAChR expression through PPARγ-independent activation of p38 MAPK and inactivation of PI3-K/mTOR: The role of Egr-1.
    Hahn SS; Tang Q; Zheng F; Zhao S; Wu J
    Cell Signal; 2014 Apr; 26(4):730-9. PubMed ID: 24412748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.
    Lu X; Bijli KM; Ramirez A; Murphy TC; Kleinhenz J; Hart CM
    Free Radic Biol Med; 2013 Oct; 63():151-60. PubMed ID: 23684777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
    Green DE; Murphy TC; Kang BY; Bedi B; Yuan Z; Sadikot RT; Hart CM
    Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L371-L383. PubMed ID: 28522568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway.
    Cui C; Zhang H; Guo LN; Zhang X; Meng L; Pan X; Wei Y
    Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27474499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation.
    Yeligar SM; Kang BY; Bijli KM; Kleinhenz JM; Murphy TC; Torres G; San Martin A; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2018 May; 58(5):648-657. PubMed ID: 29182484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.
    Gong K; Xing D; Li P; Aksut B; Ambalavanan N; Yang Q; Nozell SE; Oparil S; Chen YF
    Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L899-907. PubMed ID: 21926264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib Inhibits Hypoxia-Induced Proliferation by Suppressing Caveolin-1/SOCE/[Ca
    Wang C; Li Y; Xu L; Zhang Q; Gegentuya ; Tian G
    Biomed Res Int; 2021; 2021():5551504. PubMed ID: 33928148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.
    Wang Y; Lu W; Yang K; Wang Y; Zhang J; Jia J; Yun X; Tian L; Chen Y; Jiang Q; Zhang B; Chen X; Wang J
    J Mol Med (Berl); 2015 Mar; 93(3):327-42. PubMed ID: 25391250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
    Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration.
    Song JL; Zheng SY; He RL; Gui LX; Lin MJ; Sham JSK
    Vascul Pharmacol; 2021 Jun; 138():106860. PubMed ID: 33794383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.